Selected article for: "death increase risk and increase risk"

Author: Shuya Lu; Qi Zhou; Liping Huang; Qianling Shi; Siya Zhao; Zijun Wang; Weiguo Li; Yuyi Tang; Yanfang Ma; Xufei Luo; Toshio Fukuoka; Hyeong Sik Ahn; Myeong Soo Lee; Zhengxiu Luo; Enmei Liu; Yaolong Chen; Chenyan Zhou; Donghong Peng
Title: Effectiveness and Safety of Glucocorticoids to Treat COVID-19: A Rapid Review and Meta-Analysis
  • Document date: 2020_4_22
  • ID: 935r7w01_58
    Snippet: In conclusion, glucocorticoid therapy may increase the risk of death in patients with coronavirus infections who have mild symptoms. We found no association between glucocorticoids and mortality in patients with severe symptoms. In the context of clinical trials, low dose systemic glucocorticoid therapy for a short duration may be acceptable. author/funder, who has granted medRxiv a license to display the preprint in perpetuity......
    Document: In conclusion, glucocorticoid therapy may increase the risk of death in patients with coronavirus infections who have mild symptoms. We found no association between glucocorticoids and mortality in patients with severe symptoms. In the context of clinical trials, low dose systemic glucocorticoid therapy for a short duration may be acceptable. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents